Quest Diagnostics Inc. Stock
Price
Target price
€169.75
€169.75
-0.090%
-0.15
-0.090%
€170.67
07.04.26 / Tradegate
WKN: 904533 / Symbol: DGX / Name: Quest Diagnostcs / Stock / Healthcare Providers & Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Quest Diagnostics Inc. Stock
With only a change of -€0.150 (-0.090%) the Quest Diagnostics Inc. price is nearly unchanged from yesterday.
Quest Diagnostics Inc. is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
At the moment Quest Diagnostics Inc. has reached the predicted target price of 170 €, with a current price of 169.75 €.
Pros and Cons of Quest Diagnostics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Quest Diagnostics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Quest Diagnostics Inc. | -0.090% | 0.118% | -1.078% | 12.753% | 13.812% | 29.778% | 57.760% |
| Anthem Inc. | 3.110% | 6.198% | 7.816% | -30.616% | -8.628% | -39.414% | -9.367% |
| HCA Holdings Inc. | 3.860% | 3.201% | -8.036% | 39.742% | 4.841% | 70.420% | 168.895% |
| Universal Health Services B | 2.600% | -3.106% | -11.864% | -1.266% | -18.750% | 33.106% | 35.534% |
Comments
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics (NYSE:DGX) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for DGX provided by MarketBeat